Stock DNA
Medical Specialties
CAD 334 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.47
-36.66%
9.88
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - May 2023)
Net Profit:
-4 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.97%
EBIT Growth (5y)
-201.05%
EBIT to Interest (avg)
-5.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.47
Sales to Capital Employed (avg)
0.94
Tax Ratio
2.29%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
9.88
EV to EBIT
-25.43
EV to EBITDA
-30.57
EV to Capital Employed
17.66
EV to Sales
6.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-69.43%
ROE (Latest)
-36.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 14 Schemes (15.35%)
Foreign Institutions
Held by 6 Foreign Institutions (6.15%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - May'23 - QoQ
May'23
Nov'22
Change(%)
Net Sales
13.20
10.20
29.41%
Operating Profit (PBDIT) excl Other Income
-3.50
-3.30
-6.06%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.20
-3.60
-16.67%
Operating Profit Margin (Excl OI)
-305.60%
-375.70%
7.01%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Aug'22
Aug'22
Aug'21
Change(%)
Net Sales
35.30
34.50
2.32%
Operating Profit (PBDIT) excl Other Income
-9.60
0.50
-2,020.00%
Interest
0.60
1.00
-40.00%
Exceptional Items
0.00
0.70
-100.00%
Consolidate Net Profit
-11.40
-1.20
-850.00%
Operating Profit Margin (Excl OI)
-322.90%
-37.70%
-28.52%
USD in Million.
Net Sales
YoY Growth in year ended Aug 2022 is 2.32% vs 16.95% in Aug 2021
Consolidated Net Profit
YoY Growth in year ended Aug 2022 is -850.00% vs 53.85% in Aug 2021






